Indraprastha Medical Corporation Limited
Indraprastha Medical Corporation Limited Fundamental Analysis
Indraprastha Medical Corporation Limited (INDRAMEDCO.BO) shows moderate financial fundamentals with a PE ratio of 20.40, profit margin of 12.60%, and ROE of 30.79%. The company generates $14.5B in annual revenue with moderate year-over-year growth of 8.97%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 67.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze INDRAMEDCO.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentINDRAMEDCO.BO demonstrates superior asset utilization.
Valuation Score
ModerateINDRAMEDCO.BO shows balanced valuation metrics.
Growth Score
ExcellentINDRAMEDCO.BO delivers strong and consistent growth momentum.
Financial Health Score
ExcellentINDRAMEDCO.BO maintains a strong and stable balance sheet.
Profitability Score
WeakINDRAMEDCO.BO struggles to sustain strong margins.
Key Financial Metrics
Is INDRAMEDCO.BO Expensive or Cheap?
P/E Ratio
INDRAMEDCO.BO trades at 20.40 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, INDRAMEDCO.BO's PEG of 4.37 indicates potential overvaluation.
Price to Book
The market values Indraprastha Medical Corporation Limited at 5.67 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 14.25 times EBITDA. This signals the market has high growth expectations.
How Well Does INDRAMEDCO.BO Make Money?
Net Profit Margin
For every $100 in sales, Indraprastha Medical Corporation Limited keeps $12.60 as profit after all expenses.
Operating Margin
Core operations generate 15.47 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $30.79 in profit for every $100 of shareholder equity.
ROA
Indraprastha Medical Corporation Limited generates $19.17 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Indraprastha Medical Corporation Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Indraprastha Medical Corporation Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
INDRAMEDCO.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
20.40
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
4.37
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.67
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.57
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.05
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.67
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.31
vs 25 benchmark
ROA
Return on assets percentage
0.19
vs 25 benchmark
ROCE
Return on capital employed
0.31
vs 25 benchmark
How INDRAMEDCO.BO Stacks Against Its Sector Peers
| Metric | INDRAMEDCO.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 20.40 | 29.45 | Better (Cheaper) |
| ROE | 30.79% | 779.00% | Weak |
| Net Margin | 12.60% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.05 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 2.67 | 4.65 | Strong Liquidity |
| ROA | 19.17% | -19344.00% (disorted) | Strong |
INDRAMEDCO.BO outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Indraprastha Medical Corporation Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
70.24%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
269.01%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
81.30%
Industry Style: Defensive, Growth, Innovation
High Growth